AMED - Amedisys, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 54.19B
Enterprise Value 34.54B
Trailing P/E 34.54
Forward P/E 128.44
PEG Ratio (5 yr expected) 12.24
Price/Sales (ttm)2.31
Price/Book (mrq)7.45
Enterprise Value/Revenue 32.50
Enterprise Value/EBITDA 625.20

Trading Information

Stock Price History

Beta (3Y Monthly) 1.32
52-Week Change 36.61%
S&P500 52-Week Change 30.90%
52 Week High 3141.98
52 Week Low 397.38
50-Day Moving Average 3130.42
200-Day Moving Average 3123.59

Share Statistics

Avg Vol (3 month) 3330.63k
Avg Vol (10 day) 3181.04k
Shares Outstanding 532.04M
Float 31.84M
% Held by Insiders 11.16%
% Held by Institutions 192.98%
Shares Short (Jul 31, 2019) 41.61M
Short Ratio (Jul 31, 2019) 44.93
Short % of Float (Jul 31, 2019) 47.03%
Short % of Shares Outstanding (Jul 31, 2019) 45.01%
Shares Short (prior month Jun 28, 2019) 41.73M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 23/4
Last Split Date 3Dec 5, 2006

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 6.84%
Operating Margin (ttm)9.13%

Management Effectiveness

Return on Assets (ttm)10.55%
Return on Equity (ttm)25.69%

Income Statement

Revenue (ttm)1.81B
Revenue Per Share (ttm)56.70
Quarterly Revenue Growth (yoy)19.80%
Gross Profit (ttm)669.72M
EBITDA 180.01M
Net Income Avi to Common (ttm)123.88M
Diluted EPS (ttm)3.77
Quarterly Earnings Growth (yoy)1.20%

Balance Sheet

Total Cash (mrq)13.9M
Total Cash Per Share (mrq)0.43
Total Debt (mrq)357.66M
Total Debt/Equity (mrq)63.53
Current Ratio (mrq)0.88
Book Value Per Share (mrq)17.49

Cash Flow Statement

Operating Cash Flow (ttm)211.84M
Levered Free Cash Flow (ttm)189.04M